INFQ:NYSEInfleqtion, Inc. Analysis
Data as of 2026-06-17 - not real-time
$13.73
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Infleqtion, Inc. (INFQ) has entered a pivotal phase, with its recent UK Quantum Innovation Centre launch boosting market enthusiasm and driving the stock higher. Technically, the price sits above the 200‑day SMA but below the 20‑day and 50‑day SMAs, while the RSI hovers near the midpoint, suggesting limited upside momentum. The MACD histogram remains negative, flagging bearish short‑term pressure, and volume trends are declining, tempering the rally. However, the company’s cash balance of over $400 million dwarfs its modest $33 million revenue base, providing a substantial liquidity cushion despite negative operating cash flow and a recent max drawdown of more than 40 percent. The extreme beta of nearly five and a 30‑day volatility above 150 percent underline a high‑risk, high‑reward profile. Coupled with news of a 100‑qubit quantum computer delivery and a new ETF targeting INFQ, the narrative is strongly growth‑oriented, though fundamentals remain weak.
Investors should weigh the bullish sentiment from strategic partnerships and government‑backed expansion against the overvalued pricing metrics—price‑to‑sales near 90 and price‑to‑book above five—while recognizing the speculative nature of the quantum‑technology sector.
Investors should weigh the bullish sentiment from strategic partnerships and government‑backed expansion against the overvalued pricing metrics—price‑to‑sales near 90 and price‑to‑book above five—while recognizing the speculative nature of the quantum‑technology sector.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD histogram and declining volume
- Recent price rally driven by news rather than fundamentals
- High short‑term volatility and beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic UK expansion and first 100‑qubit delivery
- Strong cash position supporting R&D and scale‑up
- Potential upside of over 50 percent based on upside/downside estimate
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Quantum‑technology market still nascent with execution risk
- Continued earnings losses and negative cash flow
- Valuation remains stretched relative to revenue and book value
Key Metrics & Analysis
Financial Health
Revenue Growth13.90%
Profit Margin-166.77%
P/E Ratio-91.1
Debt/Equity0.84
P/B Ratio5.1
Op. Cash Flow$-36332000
Industry P/E37.7
Technical Analysis
TrendBullish
RSI47.4
Support$10.45
Resistance$20.75
MA 20$15.28
MA 50$14.03
MA 200$12.88
MACDBearish
VolumeDecreasing
Fear & Greed Index91.3
Valuation
Target Price$21.00
Upside/Downside52.95%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta5.00
Volatility152.95%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.